Analysis of C. difficile infection–related outcomes in European participants in the bezlotoxumab MODIFY I and II trials

  1. Bouza, E.
  2. Cornely, O.A.
  3. Ramos-Martinez, A.
  4. Plesniak, R.
  5. Ellison, M.C.
  6. Hanson, M.E.
  7. Dorr, M.B.
Journal:
European Journal of Clinical Microbiology and Infectious Diseases

ISSN: 1435-4373,  0934-9723

Year of publication: 2020

Volume: 39

Issue: 10

Pages: 1933-1939

Type: Article

DOI: 10.1007/S10096-020-03935-3 GOOGLE SCHOLAR lock_openOpen access editor
Data source: Scopus